NCPC Huasheng Pharmaceutical

NCPC Huasheng Pharmaceutical is a prominent subsidiary of the North China Pharmaceutical Group Corporation (NCPC), specializing in the manufacture of anti-infective medicines. The company is a major global producer of aminoglycoside and tetracycline antibiotics, including Streptomycin Sulfate and Oxytetracycline. Operating out of Shijiazhuang, China, it maintains large-scale fermentation and chemical synthesis capabilities that adhere to international GMP standards. Its products are distributed extensively in both domestic and international markets, supporting the treatment of various bacterial infections and tuberculosis. The firm serves as a critical manufacturing hub within the broader NCPC ecosystem, focusing on high-quality API production and finished dosage forms.